Summary
Intravesical and intradermal application of B.C.G. (Bacillus Calmette Guérin) has proven to be effective in the prophylaxis of recurrence of superficial bladder carcinoma after transurethral resection and in the treatment of carcinoma in situ (C.I.S.) in man. Different strains of B.C.G. have been used for this purpose. In this article a new strain of B.C.G. (B.C.G.-R.I.V.M.) has been tested to assess its toxicity. The effects of intravesical and intradermal application of B.C.G.-R.I.V.M. were studied on normal and on coagulated canine urothelium. In this study no general side effects of B.C.G.-R.I.V.M. were seen. Only minor local changes occurred in the bladder wall. Small granulomas were found in the suburothelial tissue. No granulomas or signs of active inflammation were observed in the pelvic lymphnodes, spleen and liver. Because B.C.G.-R.I.V.M. seemed to be a safe agent in the dog we have started to use it for prophylaxis in superficial bladder cancer in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bloomberg SD, Brosman SA, Hausman MS, Cohen A, Battenberg JD (1975) The effects of B.C.G. on the dog bladder. Invest Urol 12:423
Brosman SA (1982) Experience with Bacillus Calmette-Guérin in patients with superficial bladder cancer. J Urol 128:27
Camacho F, Pinsky CM, Kerr D, Whitmore WE Jr, Oettgen H (1980) Treatment of superficial bladder cancer with intravesical B.C.G. ASCO Proc 21:359
Herr HW, Pinsky CM, Whitmore WF Jr, Oettgen HF, Melamed MR (1983) Effect of intravesical Bacillus Calmette-Guérin (B.C.G.) on carcinoma in situ of the bladder. Cancer 51:1323
De Jong WH, Steerenberg PA, Kreeftenberg JG, Tiesjema RH, Kruizinga W, van Noorle Jansen LM, Ruitenberg EJ (1984) Experimental screening of B.C.G. preparations produced for cancer immunotherapy: Safety and immunostimulating and antitumor activity of four consecutively produced batches. Cancer Immunol Immunother 17:18
Klein WR, Ruitenberg EJ, Steerenberg PA, de Jong WH, Kruizinga W, Misdorp W, Bier J, Tiesjema RH, Kreeftenberg JG, Teppema JS, Rapp HJ (1982) Immunotherapy by intralesional injection of B.C.G. cell walls or live B.C.G. in bovine ocular squamous cell carcinoma: a preliminary report. INCI 69:1095
Klein WR, Bras GE, Misdorp W, Steerenberg PA, de Jong WH, Tiesjema RH, Kersjes AW, Ruitenberg EJ (1985) Equine sarcoid: B.C.G. immunotherapy compared to cryosurgery in a prospective randomised clinical trial cancer. Immunol Immunother
Kreeftenberg JG, de Jong WH, Ettekoven H, Steerenberg PA, Kruizinga W, van Noorle Jansen LM, Sekhuis J, Ruitenberg EJ (1981) Experimental screening of two B.C.G. preparations produced according to different principles. Cancer Immunol Immunother 12:21
Lamm DL, Thor DE, Winters WD, Stogdill VD, Radwin HM (1981) B.C.G. immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses. Cancer 48:82
Lamm DL, Thor DE, Harris SC, Reyna JA, Stogdill VD, Radwin HM (1980) Bacillus Calmette-Guérin immunotherapy of superficial bladder cancer. J Urol 124:38
Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 116:180
Morales A, Ottenhof P, Emmerson L (1981) Treatment of residual non-infiltrating bladder cancer with Bacillus Calmette-Guérin. J Urol 125:649
Morales A (1984) Long-term results and complications of intracavitary Bacillus Calmette-Guérin therapy for bladder cancer. J Urol 132:457
Ruitenberg EJ, Tiesjema RH, Kreeftenberg JG, Steerenberg PA, de Jong WH, Kruizinga W, Smid P, van Noorle Jansen LM (1982) Some characteristics of B.C.G./R.I.V. lot no. 077, prepared to be used for immunostimulation in cancer immunotherapy. Report No. 157402009, National Institute of Public Health, Bilthoven, The Netherlands
Shapiro A, Kadmon D, Catalona WJ, Ratliff TL (1982) Immunotherapy of superficial bladder cancer. J Urol 128:891
Author information
Authors and Affiliations
Additional information
Grant recipient of the Koningin Wilhelmina Fonds (Dutch Cancer Foundation)
Rights and permissions
About this article
Cite this article
Meijden, A.P.M.v.d., Steerenberg, P.A., de Jong, W.H. et al. The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder. Urol. Res. 14, 207–210 (1986). https://doi.org/10.1007/BF00441115
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441115